Key facts
- Notable investors include I2BF Global Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for PropelRx
- ·The full record, as it builds
Funding rounds
No funding rounds for PropelRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PropelRx
Developer of a fundraising operating system designed to streamline the process of diagnosing investment readiness, aligning capital strategies, and executing investor outreach. The company's platform offers structured workflows, integrated analytics, and automated outreach tools, enabling startups and growth-stage companies to efficiently manage fundraising activities, improve investor engagement, and increase the likelihood of securing capital through data-driven decision-making and process optimization.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2025
- Website
- propelrx.ai/
- Ownership
- Privately Held (backing)
PropelRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PropelRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PropelRx in its N-PORT filings yet. We sweep new filings monthly.